ATUL
Atul Limited
Specialty chemicals across life science and performance segments
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
atul.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Atul is a specialty chemicals maker that sells performance chemicals, bulk chemicals and intermediates, textile dyes, pharmaceutical ingredients and crop protection products to industrial and farm customers, and it is part of the Lalbhai Group.
Company snapshot
7thBy market cap
Ranked among 68 companies in Specialty Chemicals.
Segment mix
Reportable segments as of 2024-12-31 (Standalone). Revenue share = segment revenue ÷ total revenue.
Largest segment: 81.7% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Life Science Chemicals | 32.7% | 416 Cr | 96 Cr | 1,335 Cr |
| Others | 1.5% | 19 Cr | 3 Cr | 221 Cr |
| Performance and other chemicals | 81.7% | 1,041 Cr | 75 Cr | 3,712 Cr |
Shares add up to 116% because segment revenues are before inter-segment eliminations.
What we see
- ✓89% of operating profit came in as cash over the last three years — profits are backed by real cash.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,194 Cr | 1,138 Cr | 1,212 Cr | 1,322 Cr | 1,393 Cr | 1,417 Cr | 1,452 Cr | 1,478 Cr | 1,552 Cr | 1,574 Cr | 1,670 Cr | 1,848 Cr |
| Operating expenses (approx.) | 1,039 Cr | 986 Cr | 1,065 Cr | 1,099 Cr | 1,150 Cr | 1,193 Cr | 1,229 Cr | 1,243 Cr | 1,284 Cr | 1,327 Cr | 1,389 Cr | 1,454 Cr |
| EBITDA | 155 Cr | 152 Cr | 148 Cr | 223 Cr | 243 Cr | 224 Cr | 223 Cr | 236 Cr | 267 Cr | 247 Cr | 281 Cr | 394 Cr |
| OPM % | 13.0% | 13.3% | 12.2% | 16.9% | 17.4% | 15.8% | 15.4% | 15.9% | 17.2% | 15.7% | 16.8% | 21.3% |
| Other income | 22 Cr | 15 Cr | 13 Cr | 13 Cr | 32 Cr | 16 Cr | 49 Cr | 26 Cr | 49 Cr | 39 Cr | 90 Cr | 33 Cr |
| Interest | 2 Cr | 2 Cr | 5 Cr | 5 Cr | 9 Cr | 4 Cr | 5 Cr | 5 Cr | 5 Cr | 4 Cr | 4 Cr | 4 Cr |
| Depreciation | 54 Cr | 61 Cr | 76 Cr | 77 Cr | 78 Cr | 81 Cr | 82 Cr | 82 Cr | 81 Cr | 80 Cr | 79 Cr | 78 Cr |
| Profit before tax | 124 Cr | 105 Cr | 83 Cr | 158 Cr | 191 Cr | 158 Cr | 186 Cr | 177 Cr | 231 Cr | 203 Cr | 303 Cr | 346 Cr |
| Tax % | 26.2% | 31.7% | 29.2% | 28.9% | 26.9% | 25.8% | 30.1% | 25.2% | 21.1% | 19.6% | 30.3% | 26.7% |
| Net profit | 91 Cr | 72 Cr | 59 Cr | 112 Cr | 140 Cr | 117 Cr | 130 Cr | 132 Cr | 182 Cr | 164 Cr | 211 Cr | 254 Cr |
| EPS (₹) | ₹30.60 | ₹24.04 | ₹19.81 | ₹38.00 | ₹46.47 | ₹36.93 | ₹42.97 | ₹43.40 | ₹60.88 | ₹54.60 | ₹71.38 | ₹83.32 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,996 Cr | 3,338 Cr | 4,038 Cr | 4,093 Cr | 3,731 Cr | 5,081 Cr | 5,428 Cr | 4,726 Cr | 5,583 Cr | 6,274 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 2,487 Cr | 2,833 Cr | 3,271 Cr | 3,191 Cr | 2,814 Cr | 4,169 Cr | 4,653 Cr | 4,089 Cr | 4,670 Cr | 5,243 Cr | Sign in free for the trailing twelve months |
| EBITDA | 509 Cr | 505 Cr | 767 Cr | 902 Cr | 917 Cr | 911 Cr | 775 Cr | 637 Cr | 913 Cr | 1,031 Cr | Sign in free for the trailing twelve months |
| OPM % | 17.0% | 15.1% | 19.0% | 22.0% | 24.6% | 17.9% | 14.3% | 13.5% | 16.4% | 16.4% | Sign in free for the trailing twelve months |
| Other income | 53 Cr | 26 Cr | 35 Cr | 78 Cr | 103 Cr | 76 Cr | 115 Cr | 58 Cr | 109 Cr | 203 Cr | Sign in free for the trailing twelve months |
| Interest | 25 Cr | 13 Cr | 7 Cr | 9 Cr | 9 Cr | 9 Cr | 8 Cr | 11 Cr | 24 Cr | 17 Cr | Sign in free for the trailing twelve months |
| Depreciation | 95 Cr | 110 Cr | 119 Cr | 130 Cr | 136 Cr | 177 Cr | 198 Cr | 243 Cr | 317 Cr | 322 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 446 Cr | 412 Cr | 680 Cr | 845 Cr | 882 Cr | 802 Cr | 688 Cr | 451 Cr | 692 Cr | 915 Cr | Sign in free for the trailing twelve months |
| Tax % | 27.5% | 31.8% | 35.9% | 20.6% | 25.1% | 25.6% | 26.3% | 28.1% | 28.0% | 24.6% | Sign in free for the trailing twelve months |
| Net profit | 323 Cr | 281 Cr | 436 Cr | 671 Cr | 660 Cr | 597 Cr | 507 Cr | 324 Cr | 499 Cr | 689 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹109.01 | ₹94.82 | ₹147.00 | ₹224.69 | ₹221.17 | ₹204.23 | ₹174.15 | ₹109.54 | ₹164.37 | ₹230.25 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 0.0% | 9.9% | 1.6% | 22.8% | 11.8% | 10.7% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 30 Cr | 30 Cr | 30 Cr | 30 Cr | 30 Cr | 30 Cr | 30 Cr | 29 Cr | 29 Cr | 29 Cr |
| Reserves | 1,936 Cr | 2,214 Cr | 2,676 Cr | 3,125 Cr | 3,797 Cr | 4,399 Cr | 4,642 Cr | 5,085 Cr | 5,569 Cr | 6,193 Cr |
| Borrowings | 145 Cr | 16 Cr | 52 Cr | 97 Cr | 102 Cr | 138 Cr | 47 Cr | 232 Cr | 198 Cr | 180 Cr |
| Other liabilities | 601 Cr | 734 Cr | 762 Cr | 872 Cr | 978 Cr | 1,108 Cr | 1,002 Cr | 1,081 Cr | 1,141 Cr | 1,424 Cr |
| Total liabilities | 2,727 Cr | 3,014 Cr | 3,544 Cr | 4,150 Cr | 4,937 Cr | 5,706 Cr | 5,768 Cr | 6,476 Cr | 7,001 Cr | 7,900 Cr |
| Fixed assets (net) | 999 Cr | 1,000 Cr | 1,049 Cr | 1,062 Cr | 1,357 Cr | 1,576 Cr | 1,714 Cr | 2,737 Cr | 2,792 Cr | 2,619 Cr |
| CWIP | 59 Cr | 96 Cr | 172 Cr | 368 Cr | 250 Cr | 420 Cr | 1,033 Cr | 281 Cr | 124 Cr | 110 Cr |
| Investments | 429 Cr | 470 Cr | 755 Cr | 1,141 Cr | 1,364 Cr | 1,342 Cr | 884 Cr | 1,395 Cr | 1,769 Cr | 2,595 Cr |
| Loans & advances | — | — | 0.15 Cr | 0.15 Cr | 0.13 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 419 Cr | 411 Cr | 521 Cr | 503 Cr | 594 Cr | 864 Cr | 789 Cr | 618 Cr | 729 Cr | 815 Cr |
| Trade receivables | 519 Cr | 723 Cr | 698 Cr | 720 Cr | 733 Cr | 989 Cr | 845 Cr | 927 Cr | 1,126 Cr | 1,271 Cr |
| Cash & bank | 23 Cr | 43 Cr | 38 Cr | 26 Cr | 47 Cr | 58 Cr | 38 Cr | 60 Cr | 51 Cr | 85 Cr |
| Other assets | 279 Cr | 270 Cr | 310 Cr | 331 Cr | 592 Cr | 457 Cr | 465 Cr | 458 Cr | 409 Cr | 404 Cr |
| Total assets | 2,727 Cr | 3,014 Cr | 3,544 Cr | 4,150 Cr | 4,937 Cr | 5,706 Cr | 5,768 Cr | 6,476 Cr | 7,001 Cr | 7,900 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 392 Cr | 356 Cr | 404 Cr | 881 Cr | 718 Cr | 231 Cr | 707 Cr | 667 Cr | 603 Cr | 1,023 Cr |
| Cash from investing | -173 Cr | -130 Cr | -407 Cr | -786 Cr | -646 Cr | -168 Cr | -469 Cr | -683 Cr | -495 Cr | -895 Cr |
| Cash from financing | -212 Cr | -207 Cr | -1 Cr | -108 Cr | -52 Cr | -57 Cr | -257 Cr | 38 Cr | -84 Cr | -98 Cr |
| Net cash flow | 7 Cr | 18 Cr | -5 Cr | -12 Cr | 21 Cr | 11 Cr | -20 Cr | 22 Cr | 25 Cr | 34 Cr |
| Free cash flow (OCF − Capex) | 175 Cr | 213 Cr | 195 Cr | 507 Cr | 395 Cr | -359 Cr | -168 Cr | 164 Cr | 333 Cr | 848 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 22.2% | 18.6% | 24.7% | 26.1% | 22.5% | 17.6% | 14.6% | 8.6% | 12.2% | 14.4% |
| ROE % | 16.3% | 12.2% | 16.0% | 20.9% | 17.0% | 13.4% | 10.9% | 6.3% | 8.5% | 10.8% |
| Debtor days | 63 | 79 | 63 | 64 | 72 | 71 | 57 | 72 | 73 | 74 |
| Inventory days | 109 | 86 | 86 | 101 | 135 | 121 | 110 | 102 | 95 | 91 |
| Days payable | 88 | 96 | 63 | 96 | 128 | 89 | 75 | 96 | 80 | 95 |
| Cash conversion cycle | 84 | 69 | 86 | 69 | 79 | 103 | 92 | 78 | 88 | 70 |
| OCF / EBITDA % | 76.9% | 70.4% | 52.6% | 97.7% | 78.3% | 25.4% | 91.2% | 104.8% | 66.1% | 99.2% |
| OCF / EBITDA % (3 years) | — | — | 64.6% | 75.5% | 77.5% | 67.0% | 63.6% | 69.1% | 85.1% | 88.9% |
| Debt / equity | 0.07 | 0.0071 | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 | 0.05 | 0.04 | 0.03 |
| Current ratio | 1.92 | 2.38 | 2.88 | 2.84 | 3.18 | 2.69 | 2.49 | 2.56 | 3.33 | 3.61 |
| Net debt / EBITDA | 0.24 | -0.05 | 0.02 | 0.08 | 0.06 | 0.09 | 0.01 | 0.27 | 0.16 | 0.09 |